Skip to content
drillr.ai
Sign up

OKYO

OKYO Pharma Limited

NASDAQ · Healthcare · Biotechnology · GB

$1.57
+1.29%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue—————
Cost of Revenue3.1K6.7M2.6K7.5M6.7M
Gross Profit(3.1K)(6.7M)(2.6K)(7.5M)(6.7M)
Operating Expenses
R&D Expense4.1M1.8M2.3M8.2M6.3M
SG&A Expense12.3M—4.9M—6.7M
General & Admin Expense—————
Selling & Marketing Expense—————
Other Expenses————(6.7M)
Total Operating Expenses16.4M1.8M7.2M8.2M6.3M
Cost and Expenses16.4M8.5M7.2M15.7M13.1M
Operating Income (EBIT)(16.4M)(8.5M)(7.2M)(15.7M)(13.1M)
Non-Operating
Interest Income5.5K32.1K5.5K——
Interest Expense1.3M473.9K883.6K1.1M96.7K
Net Interest Income(1.3M)(441.8K)(878.2K)(1.1M)(96.7K)
Other Non-Op Income/Expense(523.8K)(442.1K)(781.2K)(1.1M)(196.4K)
Non-Operating Income (excl Interest)(759.1K)(31.8K)(102.5K)——
EBT (Pre-Tax Income)(16.9M)(8.9M)(8.0M)(16.8M)(13.3M)
Income Tax Expense(3.3M)8.0K(3.3M)22.4K(12.0K)
Bottom Line
Net Income(13.7M)(8.9M)(4.7M)(16.8M)(13.3M)
Earnings from Cont. Ops(13.7M)(8.9M)(4.7M)(16.8M)(13.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(13.7M)(8.9M)(4.7M)(16.8M)(13.3M)
Per Share
Basic EPS($0.36)($0.24)($0.12)($0.00)($0.60)
Diluted EPS($0.36)($0.24)($0.12)($0.00)($0.60)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding37.4M37.4M39.5M29.3M22.3M
Diluted Shares Outstanding37.4M37.4M39.5M29.3M22.3M
Profitability Metrics
EBITDA(15.6M)(8.5M)(7.1M)(15.7M)(13.1M)
D&A5.7K1.8K2.6K3.9K3.8K
EBIT(15.6M)(8.5M)(7.1M)(15.7M)(13.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026